{"id":204323,"date":"2025-01-22T21:07:30","date_gmt":"2025-01-23T03:07:30","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/01\/xenon-gas-revealed-as-potential-alzheimers-disease-treatment-leading-to-clinical-trial"},"modified":"2025-01-22T21:07:30","modified_gmt":"2025-01-23T03:07:30","slug":"xenon-gas-revealed-as-potential-alzheimers-disease-treatment-leading-to-clinical-trial","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/01\/xenon-gas-revealed-as-potential-alzheimers-disease-treatment-leading-to-clinical-trial","title":{"rendered":"Xenon Gas Revealed As Potential Alzheimer\u2019s Disease Treatment, Leading To Clinical Trial"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/xenon-gas-revealed-as-potential-alzheimers-disease-treatment-leading-to-clinical-trial2.jpg\"><\/a><\/p>\n<p>Alzheimer\u2019s disease (AD), the most prevalent neurodegenerative disorder, continues to pose significant challenges despite advances in anti-amyloid therapies. New research from Harvard Medical School and Washington University School of Medicine, published in <em>Science Translational Medicine<\/em>, has unveiled a novel therapeutic approach: the use of inhaled xenon gas to modulate microglia and ameliorate disease progression in mouse models of AD.<\/p>\n<p><strong>How Xenon Targets Microglia<\/strong><\/p>\n<p>Microglia, the brain\u2019s resident immune cells, play a dual role in neurodegeneration. While they can clear amyloid-beta (A\u03b2) plaques and damaged neurons, chronic activation leads to neuroinflammation, contributing to disease progression. Xenon gas, an inert anaesthetic, penetrates the blood-brain barrier and appears to modulate microglia to adopt a \u201cpre-neurodegenerative microglia\u201d (pre-MGnD) state.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alzheimer\u2019s disease (AD), the most prevalent neurodegenerative disorder, continues to pose significant challenges despite advances in anti-amyloid therapies. New research from Harvard Medical School and Washington University School of Medicine, published in Science Translational Medicine, has unveiled a novel therapeutic approach: the use of inhaled xenon gas to modulate microglia and ameliorate disease progression in [\u2026]<\/p>\n","protected":false},"author":692,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-204323","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/204323","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/692"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=204323"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/204323\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=204323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=204323"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=204323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}